STAT

OCTOBER 17, 2023

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

353

353

STAT

MARCH 4, 2024

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

246

246

STAT

JUNE 6, 2023

Freshly minted life science Ph.D. graduates who have started families or have big loans, or are Black or female, say they plan to pursue postdoc positions at lower rates than their peers, according to a STAT analysis that includes previously unreported data from the National Center for Science and Engineering Statistics.

304

304

PharmaVoice

APRIL 30, 2024

From resurrecting an extinct species to improving regenerative medicines with plant-based materials, these biotechs are on the leading edge of science.

130

130

STAT

OCTOBER 19, 2023

Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

Compounding 335

Compounding 335

STAT

APRIL 27, 2023

Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Editor’s Note: A livestream of the event will be embedded below at 1 p.m. Read the rest…

246

246

pharmaphorum

MAY 2, 2024

Pursue your passion for science with a rewarding career in life sciences. Learn how a job in biology, biotech, or health sciences offers intellectual stimulation and the chance to improve lives.

114

114

STAT

OCTOBER 11, 2023

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

341

341

STAT

FEBRUARY 12, 2024

And while the occasion is most closely associated with ads for beer, cars, and soft drinks, pharma giant Pfizer dished out millions of dollars for its own message: “Here’s to science.”

Hospitals 350

Hospitals 350

STAT

MARCH 27, 2023

A recent high-profile paper suggesting that science is becoming dramatically less disruptive set the academic world abuzz. So although “scientists are increasingly citing famous work” sounds somewhat innocuous, the underlying knowledge overload poses a genuine threat. Read the rest…

246

246

pharmaphorum

FEBRUARY 5, 2024

Data science in healthcare is transforming the industry, from drug discovery to patient care. Learn about the role of data, artificial intelligence (AI), and the impact of initiatives like the NHS Datastore in revolutionising healthcare outcomes.

129

129

STAT

SEPTEMBER 26, 2023

Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’ Immunovant showed the treatment could reduce the levels of a key immune marker in the blood, a promising signal.

Immunity 322

Immunity Immunization Drug Development 322

STAT

APRIL 30, 2024

LA JOLLA, Calif. — About a half century ago, a barren ocean bluff here started sprouting research institutions, turning a backwater Navy town into a much-envied icon of high-tech jobs and biomedical discoveries.

Drug Development 266

Drug Development 266

pharmaphorum

MARCH 8, 2024

Celebrate International Women’s Day by learning about Miruna Sasu, a prominent female figure in the life sciences field and CEO of COTA. Explore how the company uses AI in the oncology space.

119

119

pharmaphorum

MARCH 8, 2024

Angie Franks is a prominent female figure in the life sciences industry and perfect to highlight on International Women's Day. Learn more about her contributions and achievements in healthcare and technology.

119

119

STAT

NOVEMBER 13, 2023

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague. Continue to STAT+ to read the full story…

260

260

Outsourcing Pharma

MAY 9, 2024

A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.

94

94

STAT

OCTOBER 10, 2023

To be sure, the life sciences sector remains robust, a major pillar of the economy, and companies are generally happy to pick up talent cast aside. As associate director of manufacturing sciences and technology, Janoschek acted as a liaison between Sunovion and companies that made its medicines in the United States and overseas.

Vaccines 325

Vaccines Generic Medicine Drug Development Packaging 325

Express Pharma

APRIL 4, 2024

The companies will join forces to advance the use of precision medicine on a global scale SOPHiA GENETICS, a cloud-native software company in the healthcare space has announced a strategic partnership with Strand Life Sciences to deliver innovative solutions that will fuel the use of precision medicine globally.

93

93

STAT

SEPTEMBER 1, 2022

In 2021, Jennifer Huberty left her post in academia to become the first full-time head of science at Calm. A year later, Huberty has departed the company to strike out on her own as a scientific consultant for digital health companies, and the future of her science team and the company’s broader research efforts is unclear.

246

246

STAT

MARCH 20, 2023

Now she’s in charge of a multibillion-dollar operation tasked with spotting talent, incubating breakthroughs, and doing for the life sciences what DARPA did for technology.

267

267

STAT

DECEMBER 15, 2022

The leading journals Science and Cell on Thursday issued “expressions of concern” on papers co-authored by Stanford University president Marc Tessier-Lavigne, who is under investigation over allegations of research misconduct. Read the rest…

246

246

Express Pharma

APRIL 17, 2024

Merck recently announced the appointment of Dhananjay Singh as the Managing Director of Merck Life Science in India, in addition to his current position as Head of Science & Lab Solutions Commercial, India. The post Merck appoints Dhananjay Singh as Life Science MD appeared first on Express Pharma.

66

66

Pharmafile

MAY 1, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics have announced that they have entered into a collaborative partnership with the aim of ‘deliver[ing] robust and reliable automated liquid handling solutions that enable labs to streamline operations and generate consistent results’, according to the press release.

64

64

STAT

JULY 19, 2023

Science is a team sport. Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision.

246

246

STAT

JUNE 6, 2023

It’s a topic that has garnered increasing attention in recent years , and one that has raised thorny questions about the balance between conducting open, collaborative science and protecting intellectual property. Continue to STAT+ to read the full story…

251

251

pharmaphorum

MAY 7, 2024

The life sciences sector in Ireland is booming thanks to nurturing talent and fostering innovation. Companies like Eli Lilly and Regeneron have major operations driving excellence.

64

64

STAT

JULY 5, 2023

Whether you’re looking for gripping personal stories or fascinating histories of deadly pathogens, our annual list of health, medicine, and science titles has something for everyone. With summer in full swing, it’s a great time to tuck into a new book or podcast.

246

246

STAT

OCTOBER 27, 2022

And what’s at stake for science in the midterms? We also discuss the latest news in the life sciences, including the potential effects of federal drug-price negotiation and the virtues of befriending Pharrell Williams. Can Covid denialism get you elected? How is the music business like biotech investing? Read the rest…

Drug Pricing 246

Drug Pricing Vaccines 246

STAT

MAY 25, 2023

government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. LONDON — The U.K.

Packaging 246

Packaging Pharmaceutical Manufacturing 246

STAT

NOVEMBER 10, 2022

STAT Washington correspondent Sarah Owermohle joins us to explain how this week’s midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses. Read the rest…

246

246

Outsourcing Pharma

MAY 1, 2024

We spoke with RenÃe about her journey from investment banking to science and the joy of bringing therapies to patients. RenÃe Aguiar-Lucander, CEO of Calliditas, is driving the advancement and launch of TARPEYO â the companyâs medication targeting rare disease IgA nephropathy.

102

102

pharmaphorum

OCTOBER 17, 2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.

116

116

Express Pharma

JANUARY 18, 2024

Glenmark Life Sciences has signed a Master Supply Agreement (MSA) with a Japanese innovator pharma company. Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the Japanese firm.

92

92

Pharma Times

APRIL 17, 2024

Both companies will facilitate career progression while advancing the life sciences industry

107

107

pharmaphorum

MAY 10, 2024

London's burgeoning life sciences scene is kicking off 2024 with optimism as the city prepares to host major conferences like Anglonordic. Discover how antibody discovery biotechs like Alchemab are driving growth and innovation in the sector.

59

59

Express Pharma

FEBRUARY 6, 2024

A company statement informed, “The NMR District represents the first exclusive life sciences development in Mumbai and is spread across 16 acres of land with a total development of 1.5 million square feet. million square feet. To be developed in multiple phases, this project will attract a total investment of over $150 million by RxP.”

115

115